Evec News update

>TOP >Evec News update

: 2016-07-20: Evec has started offering several contract services.
please click here
: 2014-07-17: Our anti-MPV Abs, EV046120 and EV046135, have high neutralization activities not only for MPV but also for RSV.
: 2014-06-20: Monoclonal Abs that we have generated are those for Cytomegalovirus, Clostridium difficile, RS virus, human Metapneumovirus (hMPV) and high mobility group box 1 (HMGB1). We are seeking for pharmaceutical companies who could develop these Abs toward pharmaceuticals. Please contact info@evec.jp.
please click here
: 2011-09-05: Evec signed the contract with Astellas Pharma Inc. , licensing one antibody for commercial development.
Astellas Pharma Inc.
: 2010-01-22: Kenzo Takada, MD, PhD received the Hokkaido Science and Technology Award.
: 2009-10-09: Evec had an exhibition at Bio Japan 2009（Oct 7- 9.）
: 2009-06-05: Evec received the Minister Award for Science, Technology and Innovation Policy of Japan at the 8th Business-Academia-Government Collaboration Summit (Kyoto, Jun. 20-21).
: 2009-06-01: Two-page article introduced Evec, as “a hidden worldwide enterprise”, in the Nikkei Business June issue.
: 2008-09-30: Evec signed the contract with Boehringer Ingelheim GmbH (Germany), licensing one kind of antibody for commercial development.
Boehringer Ingelheim